From Wikipedia, the free encyclopedia
Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as a immunostimulator.[1] It is developed by Ligand Pharmaceuticals (LGND) under the brand name Graslopin.
[edit] References
- ^ Amadori S, Suciu S, Jehn U, et al (2005). "Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study". Blood 106 (1): 27–34. doi:10.1182/blood-2004-09-3728. PMID 15761020.
/ 
/ 
